Tag: Pascal Soriot

AstraZeneca’s new CEO removes R&D, commercial heads

Your Health Matters

LONDON (Reuters) – AstraZeneca’s new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations in a management revamp designed to speed decision-making. Pascal Soriot, who took the helm at Britain’s second-biggest pharmaceutical company in October, said the roles held by Martin Mackay and Tony Zook respectively had been eliminated and both men would leave the company at the end of January. …

,

New CEO has work cut out as AstraZeneca sales fall

Your Health Matters

Handout photograph of AstraZeneca Chief Executive Pascal SoriotLONDON (Reuters) – AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent expiries on once best-selling medicines and a thin pipeline of new drugs, the former Roche executive, who joined on October 1, needs to re-focus operations and step up the hunt for acquisitions, analysts believe. …